ASX Filings

Ceasing to be a substantial holder

October 8, 2019

Opthea to Present at the Ophthalmology Innovation Summit in San Francisco

October 3, 2019

Additional Formats

PDF Version

Opthea Receives A$14.6m R&D Tax Incentive

October 1, 2019

Additional Formats

PDF Version

Appendix 3B

September 30, 2019

Change in substantial holding

September 13, 2019

Opthea Presents Positive Data from OPT-302 Phase 2b Wet AMD Trial at EURETINA Congress

September 6, 2019

Additional Formats

PDF Version

Opthea Presentation for EURETINA Congress

September 5, 2019

Opthea Ph2b of OPT-302 in wAMD to be Presented at EURETINA

September 4, 2019

Change in substantial holding

August 29, 2019

Change in substantial holding

August 27, 2019